The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Subacute Sclerosing Panencephalitis (SSPE)

Late Devastating Complication of Measles Virus Persistence

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Subacute Sclerosing Panencephalitis (SSPE)?

Subacute sclerosing panencephalitis (SSPE) is a chronic, progressive, fatal neurodegenerative disease caused by persistent defective measles virus infection of the central nervous system.

It typically occurs 6–8 years after natural measles infection (rarely after measles vaccination), with younger age at primary infection (especially <2 years) being the strongest risk factor.

Pathophysiology involves replication-defective measles virus in neurons and glia, evading immune clearance; pathology shows sclerosing panencephalitis with neuronal loss, gliosis, demyelination, and intranuclear viral inclusions.

Diagnosis based on clinical features, characteristic EEG (periodic Radermecker complexes), elevated CSF and serum measles antibody titers (with high CSF/serum ratio), MRI findings, and confirmed measles infection history.

Symptoms

Stage 1 (behavioral and intellectual): cognitive decline, school deterioration, behavioral changes, mood lability, irritability, lethargy
Stage 2 (myoclonic): characteristic massive myoclonic jerks (axial, occurring every 5–10 seconds), often associated with EEG burst-suppression pattern
Stage 3 (decorticate): progressive dementia, dystonia, choreoathetosis, decerebrate posturing, autonomic instability, rigidity
Stage 4 (terminal): mute, vegetative state, decerebrate posturing, autonomic dysfunction, persistent vegetative state, death typically 1–3 years after onset
Visual symptoms: chorioretinitis, optic atrophy, cortical blindness in 10–50%
Atypical fulminant presentations with rapid progression to death within weeks possible

Risk Factors

Primary measles infection at young age (especially <2 years; risk of SSPE 1 in 600–1,500 in this age group versus 1 in 100,000 overall)
Lack of measles vaccination or incomplete vaccination
Male sex (male-to-female ratio 2:1 to 3:1)
Geographic regions with low measles vaccine coverage (Asia, Africa, Eastern Europe)
Immunosuppression at time of primary measles infection
Year of birth before universal measles vaccination programs

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Child or adolescent with progressive cognitive decline, school deterioration, or behavioral change with history of measles
  • New-onset myoclonic jerks, especially axial massive jerks with characteristic EEG findings
  • Visual decline with chorioretinitis or optic atrophy in patient with prior measles
  • Rapidly progressive dementia in young patient regardless of clear measles history
  • Suspected SSPE for confirmatory testing and supportive care planning

Treatment Methods

01
Primary prevention is paramount: universal measles-mumps-rubella (MMR) vaccination at 12–15 months and 4–6 years prevents primary measles infection and thus SSPE
02
No curative therapy exists; treatments aim to slow progression and provide symptomatic relief
03
Inosine pranobex (isoprinosine) 100 mg/kg/day in divided doses is the most widely used antiviral with reported 30–35% stabilization or improvement in case series
04
Intrathecal interferon-alpha (sometimes combined with inosine pranobex) considered in selected cases at experienced centers
05
Ribavirin intravenous or intrathecal investigated in case reports and small series
06
Antiseizure medications: levetiracetam, valproate, clonazepam, or other agents for myoclonus and seizures (often refractory)
07
Supportive care: nutrition (often via gastrostomy in advanced disease), respiratory support, prevention of contractures with physical therapy, treatment of dystonia and spasticity
08
Family support, palliative care discussions, and end-of-life planning given progressive nature; genetic and reproductive counseling not specifically required as SSPE is not heritable

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Headache and Migraine

Nöroloji

What you need to know about headache types, migraine attacks, and triggering factors.

Low Back Pain

Nöroloji

Learn about the most common causes of low back pain, risk factors, and appropriate treatment approaches.

Neck Pain and Cervical Disc Herniation

Nöroloji

Learn about the symptoms and treatment options for cervical disc herniation and problems in the neck region.

Epilepsy

Nöroloji

Accurate information about epilepsy, types of seizures, and recommendations for patients and families.

Parkinson Disease

Nöroloji

Parkinson disease is caused by progressive degeneration of dopaminergic neurons and alpha-synuclein accumulation; well-timed therapy substantially improves function and quality of life.

Alzheimer's Disease and Dementia

Nöroloji

Information about early signs, diagnosis, and the care process for Alzheimer's and other types of dementia.

Multiple Sclerosis (MS)

Nöroloji

What is multiple sclerosis, who is at risk, and which treatments are applied?

Stroke

Nöroloji

What is stroke, what are the FAST signs, and why is emergency intervention critical?

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.